Grace Yan

421 total citations
10 papers, 316 citations indexed

About

Grace Yan is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Grace Yan has authored 10 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Grace Yan's work include Drug Transport and Resistance Mechanisms (5 papers), Cholesterol and Lipid Metabolism (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Grace Yan is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Cholesterol and Lipid Metabolism (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Grace Yan collaborates with scholars based in United States, Germany and Colombia. Grace Yan's co-authors include Kim L. R. Brouwer, Ira G. Schulman, Richard Martin, Raju Mohan, Xiao‐Hui Gu, Tielin Wang, Harvey J. Clewell, Mary Petrowski, Kevin B. Harris and Paul Foster and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Grace Yan

10 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grace Yan United States 9 161 98 67 55 52 10 316
Maxine Taylor United Kingdom 12 83 0.5× 111 1.1× 75 1.1× 44 0.8× 133 2.6× 14 436
Daniel Y. Hung Australia 13 138 0.9× 110 1.1× 37 0.6× 81 1.5× 113 2.2× 20 395
Ricardo Nalda‐Molina Spain 11 126 0.8× 102 1.0× 30 0.4× 38 0.7× 30 0.6× 25 437
Helen Gu United States 12 117 0.7× 112 1.1× 49 0.7× 64 1.2× 109 2.1× 19 507
Dan Todd United States 8 225 1.4× 134 1.4× 62 0.9× 69 1.3× 35 0.7× 8 392
Walid Karam Lebanon 12 148 0.9× 175 1.8× 74 1.1× 94 1.7× 97 1.9× 17 427
Chantal Masungi Belgium 8 160 1.0× 128 1.3× 52 0.8× 105 1.9× 30 0.6× 8 503
Aaron M. Moss United States 7 193 1.2× 114 1.2× 18 0.3× 45 0.8× 117 2.3× 10 453
Vinayak Hosagrahara United States 13 135 0.8× 307 3.1× 138 2.1× 53 1.0× 137 2.6× 17 598
Wei Duan China 7 253 1.6× 174 1.8× 61 0.9× 34 0.6× 71 1.4× 20 471

Countries citing papers authored by Grace Yan

Since Specialization
Citations

This map shows the geographic impact of Grace Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Yan more than expected).

Fields of papers citing papers by Grace Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Yan. The network helps show where Grace Yan may publish in the future.

Co-authorship network of co-authors of Grace Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Yan. A scholar is included among the top collaborators of Grace Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Yan. Grace Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Canaud, Bernard, et al.. (2021). Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine. Clinical Kidney Journal. 14(Supplement_4). i45–i58. 14 indexed citations
3.
Kick, Ellen K., Richard Martin, Yinong Xie, et al.. (2014). Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ. Bioorganic & Medicinal Chemistry Letters. 25(2). 372–377. 33 indexed citations
4.
Yoon, Miyoung, Gregory L. Kedderis, Grace Yan, & Harvey J. Clewell. (2014). Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study. Toxicology. 332. 52–66. 23 indexed citations
5.
Pfeifer, Nathan D., Kevin B. Harris, Grace Yan, & Kim L. R. Brouwer. (2013). Determination of Intracellular Unbound Concentrations and Subcellular Localization of Drugs in Rat Sandwich-Cultured Hepatocytes Compared with Liver Tissue. Drug Metabolism and Disposition. 41(11). 1949–1956. 30 indexed citations
6.
Yan, Grace, Miyoung Yoon, Richard R. Tidwell, et al.. (2011). A Semiphysiologically Based Pharmacokinetic Modeling Approach to Predict the Dose-Exposure Relationship of an Antiparasitic Prodrug/Active Metabolite Pair. Drug Metabolism and Disposition. 40(1). 6–17. 18 indexed citations
7.
Yan, Grace, Kim L. R. Brouwer, Gary M. Pollack, et al.. (2011). Mechanisms Underlying Differences in Systemic Exposure of Structurally Similar Active Metabolites: Comparison of Two Preclinical Hepatic Models. Journal of Pharmacology and Experimental Therapeutics. 337(2). 503–512. 18 indexed citations
8.
Martin, Richard, Tielin Wang, Paige E. Mahaney, et al.. (2009). Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). Journal of Medicinal Chemistry. 52(4). 904–907. 141 indexed citations
9.
Cao, Wei, Valérie Calabro, Grace Yan, et al.. (2009). Oligomerization is required for the activity of recombinant soluble LOX‐1. FEBS Journal. 276(17). 4909–4920. 26 indexed citations
10.
Bialek, Peter, Jascha Parkington, Jian Li, et al.. (2008). Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass. Bone. 42. S46–S46. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026